| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485627 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 02/03/2009 | US7485458 Expression vector comprising adenoviral regulatory sequences for use as tool in enhancement of heterologous gene transfer and viral expression in cells |
| 02/03/2009 | US7485456 Drug screening for a molecule capable of binding to NIK (nuclear factor kappa B inducing kinase); DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, isoforms, analogs, fragments and derivatives; gene expression |
| 02/03/2009 | US7485439 Nucleic acids encoding plasminogen fragments and methods of use |
| 02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
| 02/03/2009 | US7485422 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers |
| 02/03/2009 | US7485321 Synthetic polypeptide ligand having a 12-mer L-peptide for targeting pharmaceutical agents to intestinal epithelial tissue; when integrated as an N-terminal PIII fusion peptide of an M13 phage it can bind the phage to Caco-2 cell, IEC-6 cell, rat, mouse, pig or dog homogenate membrane fractions |
| 02/03/2009 | US7485318 Biodegradable carrier and method for preparation thereof |
| 02/03/2009 | US7485311 Vascular endothelial growth factor, brain derived neurotrophic factor and/or basic fibroblast growth factor |
| 02/03/2009 | US7485308 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
| 02/03/2009 | CA2286165C A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 01/29/2009 | WO2009015050A2 Gene expression profile for predicting ovarian cancer patient survival |
| 01/29/2009 | WO2009013794A1 INSULIN SECRETION INDUCER, AND ACCELERATOR OF INCREASE IN PANCREATIC β-CELLS |
| 01/29/2009 | WO2009013324A1 Vector particles for targeting cd34+ cells |
| 01/29/2009 | WO2009012959A1 Gene therapy of chronic granulomatous disease |
| 01/29/2009 | WO2007140339A3 Production of isoprenoids |
| 01/29/2009 | WO2007089780A3 Bmx/etk tyrosine kinase gene therapy materials and methods |
| 01/29/2009 | WO2004108882A3 Neural stem cells and methods of generating and utilizing same |
| 01/29/2009 | US20090029938 Phosphodiesterase inhibitor for treatment and prevention of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis |
| 01/29/2009 | US20090029937 Biodegradable cationic polymer gene transfer compositions and methods of use |
| 01/29/2009 | US20090029936 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/29/2009 | US20090029933 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 01/29/2009 | US20090029929 Decoy Nucleic Acid to Synoviolin Gene Promoter |
| 01/29/2009 | US20090029466 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/29/2009 | US20090029458 Chicken leukemia inhibitory factor (LIF) and gene thereof |
| 01/29/2009 | US20090029415 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/29/2009 | US20090029400 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/29/2009 | US20090029380 HUMAN MutY |
| 01/29/2009 | US20090029361 Growth differentiation factor-7 |
| 01/29/2009 | US20090028916 Loaded Microspheres |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028875 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 01/29/2009 | US20090028865 Method of treating hepatocellular carcinoma |
| 01/29/2009 | US20090028862 Emmprin antagonists and uses thereof |
| 01/29/2009 | US20090028851 Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein |
| 01/29/2009 | US20090028837 Methods for Altering the Reactivity of Plant Cell Walls |
| 01/29/2009 | US20090028835 Human transcriptome corresponding to human oocytes and use of said genes or the corresponding polypeptides to trans-differentiate somatic cells |
| 01/29/2009 | CA2694222A1 Insulin secretion inducer, and accelerator for increasing the number of pancreatic .beta.-cells |
| 01/28/2009 | EP2019144A1 Vector particles for targeting CD34+ cells |
| 01/28/2009 | EP2019138A1 Method of constructing gene transport support |
| 01/28/2009 | EP2019134A1 Gene therapy of chronic granulomatous disease |
| 01/28/2009 | EP2018873A1 Prophylactic/therapeutic agent for cancer |
| 01/28/2009 | EP1470826B1 Decoy-containing pharmaceutical compositions for the treatment of aneurysms |
| 01/28/2009 | EP1207755B1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 01/28/2009 | EP1015035B1 Vaccination by topical application of genetic vectors |
| 01/28/2009 | CN101356275A Recombinant expression of multiprotein complexes using polygenes |
| 01/28/2009 | CN101355971A Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives |
| 01/28/2009 | CN101353706A Adenovirus-transfected primary cells and methods of pathway mapping |
| 01/28/2009 | CN101353671A Preparation and use of recombinant virus vector gene A3G |
| 01/28/2009 | CN101353668A Mouse beta-alexin 1 recombinant plasmids, polypeptides, uses and preparations thereof |
| 01/28/2009 | CN101353664A siRNA molecule expression vector for specific inhibition of IL-6 receptor protein expression, and construction method and use thereof |
| 01/28/2009 | CN101353647A Simulating retrovirus of target tumor, and preparation and use thereof |
| 01/28/2009 | CN101352365A Positioner for fixing micro organs |
| 01/28/2009 | CN100455667C Fusion gene vector construction and expression as well as uses |
| 01/28/2009 | CN100455600C Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 01/28/2009 | CN100455328C Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 01/27/2009 | US7482431 KCNQ2 potassium channels |
| 01/27/2009 | US7482332 For therapy of macular degeneration, the effects of skin aging, liver degeneration, and cancer |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 01/27/2009 | US7482323 Intracellular interleukin-1 receptor antagonist and uses thereof |
| 01/27/2009 | US7482320 Modulation of smooth muscle cell proliferation |
| 01/27/2009 | US7482318 Administering polynucleotides, BCL genes or proteins, fusion proteins and/or carrier mixtures, as antiapoptotic agents |
| 01/27/2009 | US7482160 Process of making a compound by forming a polymer from a template drug |
| 01/27/2009 | US7482159 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 01/27/2009 | US7482156 Hepatocellular carcinoma specific promoter and uses thereof |
| 01/27/2009 | US7482155 chimeric construct comprising a smooth muscle cells (SMC)-specific promoter operably linked to a muscle-specific enhancer; expression cassette comprising such a chimeric construct to control expression of a therapeutic gene |
| 01/27/2009 | US7482147 polypeptides, proteins or fusion proteins having hydrolase enzyme activity, used for medical diagnosis and therapy |
| 01/27/2009 | US7482138 PAK5-related compositions and methods |
| 01/27/2009 | US7482126 Transcription factor as repressor of expression of E-cadherin; drug screening |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7481998 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 01/27/2009 | CA2438168C Modulated release particles for aerosol delivery |
| 01/27/2009 | CA2338066C Treatment of dyskinesia |
| 01/27/2009 | CA2235372C Method for treating ischemic tissue |
| 01/27/2009 | CA2225278C Recombinant mva virus, and the use thereof |
| 01/27/2009 | CA2135644C Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 01/22/2009 | WO2009012363A2 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof |
| 01/22/2009 | WO2009012263A2 Tissue-specific micrornas and compositions and uses thereof |
| 01/22/2009 | WO2009012176A2 Methods and compositions for treating brain diseases |
| 01/22/2009 | WO2009012170A1 Targeting the absence: homozygous dna deletions as signposts for cancer therapy |
| 01/22/2009 | WO2009009935A1 Replication-deficient recombinant virus, pharmaceutical composition comprising the same and the uses thereof |
| 01/22/2009 | WO2009009919A1 An escherichia coli expressing trail protein and its construction method and applications |
| 01/22/2009 | WO2008027414A3 Novel p. falciparum vaccine proteins and coding sequences |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023216 Double-Stranded Oligonucleotides |
| 01/22/2009 | US20090023207 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/22/2009 | US20090023196 Stocks of replication-deficient adenovirus |
| 01/22/2009 | US20090023152 Transcription factor MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 01/22/2009 | US20090023147 Diagnostics and therapeutics for osteoporosis |
| 01/22/2009 | US20090023145 Methods of diagnosing or prognosing Alzheimer's disease |
| 01/22/2009 | US20090022785 Permeable Capsules |
| 01/22/2009 | US20090022753 Surface proteins of streptococcus pyogenes |
| 01/22/2009 | US20090022748 Unique associated Kaposi's sarcoma virus sequences and uses thereof |